Bausch Health Companies (BHC) Long-Term Deferred Tax (2016 - 2025)
Historic Long-Term Deferred Tax for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.
- Bausch Health Companies' Long-Term Deferred Tax fell 630.71% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 630.71%. This contributed to the annual value of $2.0 billion for FY2024, which is 633.03% down from last year.
- According to the latest figures from Q3 2025, Bausch Health Companies' Long-Term Deferred Tax is $2.1 billion, which was down 630.71% from $2.0 billion recorded in Q2 2025.
- Over the past 5 years, Bausch Health Companies' Long-Term Deferred Tax peaked at $2.4 billion during Q3 2022, and registered a low of $2.0 billion during Q4 2024.
- For the 5-year period, Bausch Health Companies' Long-Term Deferred Tax averaged around $2.2 billion, with its median value being $2.2 billion (2024).
- As far as peak fluctuations go, Bausch Health Companies' Long-Term Deferred Tax skyrocketed by 2356.32% in 2021, and later plummeted by 800.37% in 2025.
- Over the past 5 years, Bausch Health Companies' Long-Term Deferred Tax (Quarter) stood at $2.3 billion in 2021, then decreased by 3.82% to $2.2 billion in 2022, then fell by 3.0% to $2.1 billion in 2023, then dropped by 6.33% to $2.0 billion in 2024, then grew by 4.17% to $2.1 billion in 2025.
- Its Long-Term Deferred Tax stands at $2.1 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $2.0 billion for Q1 2025.